Nimbus Therapeutics

Nimbus

This clinical-stage company develops small molecule medicines for patients with cancer, inflammatory diseases and metabolic disorders through a computational drug discovery engine.

Congruence Therapeutics

This biotechnology company develops small molecule medicines for patients with metabolic, neurological, immunological and oncological diseases using machine learning and biophysics.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

Dewpoint Therapeutics

This biotechnology company develops condensate-modifying small molecule drugs for patients with oncology, neurodegenerative, cardiopulmonary and metabolic diseases using an AI-enabled discovery platform.

Gain Therapeutics

This biotechnology company develops allosteric small molecule therapies for patients with neurodegenerative diseases and rare genetic disorders using an artificial intelligence drug discovery platform.

innovothera

This biotechnology company develops small-molecule therapies for fibrosis, inflammatory diseases, and cancer using an artificial intelligence drug discovery platform.

Jnana Therapeutics

This clinical-stage biotechnology company develops small molecule medicines for patients with rare and immune-mediated diseases using a proprietary chemoproteomics drug discovery platform.